{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:50:23Z","timestamp":1780458623200,"version":"3.54.1"},"reference-count":35,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2023QH102"],"award-info":[{"award-number":["ZR2023QH102"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shandong Province Natural Science Foundation Joint Fund Project","award":["ZR2021LZY044"],"award-info":[{"award-number":["ZR2021LZY044"]}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2021MH373"],"award-info":[{"award-number":["ZR2021MH373"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jinan \u201cGaoXiao 20 Tiao\u201d Funding Project Contract","award":["2020GXRC005"],"award-info":[{"award-number":["2020GXRC005"]}]},{"name":"Qilu Health Leading Talent Project, Lu Wei Talent Word (2020) no. 3, NATCM\u2019s Project of High-level Construction of Key TCM Disciplines","award":["zyyzdxk-2023116"],"award-info":[{"award-number":["zyyzdxk-2023116"]}]},{"name":"High-Level Traditional Chinese Medicine Key Disciplines of the State Administration of Traditional Chinese Medicine, External Treatment of Traditional Chinese Medicine"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n               <jats:title>Background<\/jats:title>\n               <jats:p>Myocardial ischemia\u2013reperfusion injury (MIRI) refers to severe damage to the ischemic myocardium following the restoration of blood flow, and it is a major complication of reperfusion therapy for myocardial infarction. Notably, drugs such as metoprolol have been utilized to reduce ischemia\u2013reperfusion injury. Tanshinone IIA is a major constituent extracted from <jats:italic>Salvia miltiorrhiza<\/jats:italic> Bunge. Recently, tanshinone IIA has been studied extensively in animal models for controlling MIRI. Therefore, we conducted a meta-analysis on the application of tanshinone IIA in rat models with MIRI to evaluate the therapeutic effects of tanshinone IIA.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Methods<\/jats:title>\n               <jats:p>A comprehensive search was conducted across PubMed, Web of Science, Embase, the Cochrane Library, the China National Knowledge Infrastructure database, the Wanfang database, and the Chinese Scientific Journal Database to gather studies on tanshinone IIA intervention in rat models with MIRI.We employed SYRCLE\u2019s risk of bias tool to assess study quality. The primary outcome indicators were superoxide dismutase (SOD) and malondialdehyde (MDA). Myocardial infarction area was a secondary outcome indicator. This study was registered at PROSPERO (registration number CRD 42022344447).<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Results<\/jats:title>\n               <jats:p>According to the inclusion and exclusion criteria, 15 eligible studies were selected from 295 initially identified studies. In rat models with MIRI, tanshinone IIA significantly increased SOD levels while reducing MDA levels and myocardial infarction area. Moreover, the duration of myocardial ischemia influenced the effectiveness of tanshinone IIA. However, additional high-quality research studies are needed to establish the efficacy and definitive guidelines for the use of tanshinone IIA. Animal studies demonstrated that tanshinone IIA exerted a significant therapeutic effect when the ischemia duration was less than 40 minutes. Tanshinone IIA was found to be more effective when administered via intravenous, intraperitoneal, and intragastric routes at doses above 5 mg\/kg. Additionally, treatment with tanshinone IIA at all stages\u2014prior to myocardial ischemia, after ischemia but before reperfusion, prior to ischemia and after reperfusion, and after reperfusion\u2014showed satisfactory results.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Conclusions<\/jats:title>\n               <jats:p>Tanshinone IIA enhanced SOD activity and reduced MDA levels, thereby ameliorating oxidative stress damage during MIRI. Additionally, it reduced the myocardial infarction area, indicating its effectiveness in mitigating MIRI-induced damage in rats and demonstrating a myocardial protective effect. These findings contribute valuable insights for developing MIRI treatment strategies.<\/jats:p>\n            <\/jats:sec>","DOI":"10.7717\/peerj.17885","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T10:59:52Z","timestamp":1723805992000},"page":"e17885","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of tanshinone IIA in rat models with myocardial ischemia\u2013reperfusion injury: a systematic mini-review and meta-analysis"],"prefix":"10.7717","volume":"12","author":[{"given":"Xiaobin","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Traditional Chinese Medicine External Treatment Center, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China"},{"name":"College of Acupuncture, Moxibustion and Tuina, Shandong University of Traditional Chinese Medicine,  Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hehe","family":"Jiang","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhen","family":"Xing","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqing","family":"Du","sequence":"additional","affiliation":[{"name":"College of Acupuncture, Moxibustion and Tuina, Shandong University of Traditional Chinese Medicine,  Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Li","sequence":"additional","affiliation":[{"name":"College of Acupuncture, Moxibustion and Tuina, Shandong University of Traditional Chinese Medicine,  Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Ma","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxia","family":"Ma","sequence":"additional","affiliation":[{"name":"College of Acupuncture, Moxibustion and Tuina, Shandong University of Traditional Chinese Medicine,  Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjing","family":"Li","sequence":"additional","affiliation":[{"name":"College of Acupuncture, Moxibustion and Tuina, Shandong University of Traditional Chinese Medicine,  Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"10.7717\/peerj.17885\/ref-1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10557-021-07162-6","article-title":"Angio-based fractional flow reserve, functional pattern of coronary artery disease, and prediction of percutaneous coronary intervention result: a proof-of-concept study","volume":"36","author":"Biscaglia","year":"2022","journal-title":"Cardiocasular Drugs and Therapy"},{"key":"10.7717\/peerj.17885\/ref-2","doi-asserted-by":"publisher","first-page":"115715","DOI":"10.1016\/j.jep.2022.115715","article-title":"Panax ginseng against myocardial ischemia\/reperfusion injury: A review of preclinical evidence and potential mechanisms","volume":"300","author":"Chen","year":"2023","journal-title":"Journal of Ethnopharmacology"},{"key":"10.7717\/peerj.17885\/ref-3","doi-asserted-by":"publisher","first-page":"105716","DOI":"10.1016\/j.phrs.2021.105716","article-title":"The roles of PKC-\u03b4 and PKC-\u025b in myocardial ischemia\/reperfusion injury","volume":"170","author":"Chen","year":"2021","journal-title":"Pharmacological Research"},{"key":"10.7717\/peerj.17885\/ref-4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3969\/j.issn.1672-5301.2013.07.020","article-title":"The protective effect of tanshinon II A postconditioning on myocardial ischemica\/reperfusion injury in rats","volume":"11","author":"Dai","year":"2013","journal-title":"Chinese Journal of Cardiovascular Research"},{"key":"10.7717\/peerj.17885\/ref-5","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3969\/j.issn.1004-745X.2020.05.008","article-title":"Effects of tanshinone IIA on the expressions of HMGB1, IL-1\u03b2 and SOD in myocardial ischemia-reperfusion injury in rats","volume":"29","author":"Ding","year":"2020","journal-title":"Journal of Emergency in Traditional Chinese Medicine"},{"key":"10.7717\/peerj.17885\/ref-6","doi-asserted-by":"publisher","first-page":"14129","DOI":"10.1038\/s41598-020-71079-7","article-title":"Ischemia reperfusion injury provokes adverse left ventricular remodeling in dysferlin-deficient hearts through a pathway that involves TIRAP dependent signaling","volume":"10","author":"Evans","year":"2020","journal-title":"Scientific Reports"},{"key":"10.7717\/peerj.17885\/ref-7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ejphar.2007.04.031","article-title":"Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis","volume":"568","author":"Fu","year":"2007","journal-title":"European Journal of Pharmacology"},{"issue":"3","key":"10.7717\/peerj.17885\/ref-8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3390\/antiox11030501","article-title":"Superoxide radicals in the execution of cell death","volume":"11","author":"Fujii","year":"2022","journal-title":"Antioxidants"},{"key":"10.7717\/peerj.17885\/ref-9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3892\/etm.2022.11357","article-title":"Myocardial ischemia\/reperfusion injury: mechanisms of injury and implications for management (review)","volume":"23","author":"He","year":"2022","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.7717\/peerj.17885\/ref-10","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.3969\/j.issn.1005-9202.2015.15.033","article-title":"Effect of tanshinone IIA on HMGB1 in rats after myocardial ischemia and reperfusion","volume":"35","author":"Hu","year":"2015","journal-title":"Chinese Journal of Gerontology"},{"key":"10.7717\/peerj.17885\/ref-11","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.2174\/0929867328666211108110025","article-title":"Tanshinone IIA: pharmacology, total synthesis, and progress in structure-modifications","volume":"29","author":"Huang","year":"2022","journal-title":"Current Medicinal Chemistry"},{"key":"10.7717\/peerj.17885\/ref-12","article-title":"The mechanism of AMPKa2 mediating tanshinone IIA against myocardial ischemia\/reperfusion injury","author":"Jiao","year":"2016","journal-title":"Master\u2019s thesis"},{"key":"10.7717\/peerj.17885\/ref-13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.biopha.2016.09.014","article-title":"Tanshinone IIA protects against myocardial ischemia reperfusion injury by activating the PI3K\/Akt\/mTOR signaling pathway","volume":"84","author":"Li","year":"2016","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"10.7717\/peerj.17885\/ref-14","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/aps.2017.193","article-title":"Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics","volume":"39","author":"Li","year":"2018","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.7717\/peerj.17885\/ref-15","doi-asserted-by":"publisher","first-page":"e370701","DOI":"10.1590\/acb370701","article-title":"Tanshinone IIA ameliorates myocardial ischemia\/reperfusion injury in rats by regulation of NLRP3 inflammasome activation and Th17 cells differentiation","volume":"37","author":"Li","year":"2022","journal-title":"Acta Cir\u00fargica Brasileira"},{"key":"10.7717\/peerj.17885\/ref-16","doi-asserted-by":"publisher","first-page":"e12481","DOI":"10.1111\/1755-5922.12481","article-title":"Hydromorphine postconditioning protects isolated rat heart against ischemia-reperfusion injury via activating P13K\/Akt\/eNOS signaling","volume":"36","author":"Liu","year":"2018","journal-title":"Cardiovascular Therapeutics"},{"key":"10.7717\/peerj.17885\/ref-17","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3969\/j.issn.1000-7377.2017.10.014","article-title":"Study on the protective effect of tanshinone IIA pretreatment on myocardial ischemia-reperfusion injury","volume":"46","author":"Ma","year":"2017","journal-title":"Shaanxi Medical Journal"},{"key":"10.7717\/peerj.17885\/ref-18","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s13105-022-00886-5","article-title":"Correction to: nanocurcumin protects cardiomyoblasts H9c2 from hypoxia-induced hypertrophy and apoptosis by improving oxidative balance","volume":"78","author":"Nehra","year":"2022","journal-title":"Journal of Physiology and Biochemistry"},{"key":"10.7717\/peerj.17885\/ref-19","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.7717\/peerj.17885\/ref-20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ahj.2021.11.021","article-title":"The influence of heart failure on clinical and economic outcomes among older adults \u226575 years of age with acute myocardial infarction","volume":"246","author":"Pasala","year":"2022","journal-title":"American Heart Journal"},{"key":"10.7717\/peerj.17885\/ref-21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bbabio.2005.10.003","article-title":"Mitochondrial dysfunction associated with cardiac ischemia\/reperfusion can be attenuated by oxygen tension control. Role of oxygen-free radicals and cardiolipin","volume":"1710","author":"Petrosillo","year":"2005","journal-title":"Biochimica et Biophysica Acta\/General Subjects"},{"key":"10.7717\/peerj.17885\/ref-22","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3389\/fphar.2019.00753","article-title":"Salvia miltiorrhiza in treating cardiovascular diseases: a review on its pharmacological and clinical applications","volume":"10","author":"Ren","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.7717\/peerj.17885\/ref-23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.amjmed.2016.09.014","article-title":"Trends in incidence of hospitalized acute myocardial infarction in the cardiovascular research network (CVRN)","volume":"130","author":"Reynolds","year":"2017","journal-title":"American Journal of Medicine"},{"key":"10.7717\/peerj.17885\/ref-24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5246\/jcps.2018.01.001","article-title":"Protective effects of tanshinone IIA derivative on myocardial ischemia\/reperfusion injury in rats","volume":"27","author":"Shen","year":"2018","journal-title":"Journal of Chinese Pharmaceutical Sciences"},{"key":"10.7717\/peerj.17885\/ref-25","doi-asserted-by":"publisher","first-page":"572304","DOI":"10.3389\/fphar.2020.572304","article-title":"Effect of panax notoginseng saponins on focal cerebral ischemia-reperfusion in rat models: a meta-analysis","volume":"11","author":"Sun","year":"2020","journal-title":"Frontiers in Pharmacology"},{"key":"10.7717\/peerj.17885\/ref-26","first-page":"8","article-title":"The protective effect of Tanshinone IIA on oxidative stress induced by myocardial ischemia reperfusion injury of rats","volume":"14","author":"Tang","year":"2017","journal-title":"China Medical Herald"},{"key":"10.7717\/peerj.17885\/ref-27","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.5114\/aoms\/111373","article-title":"Upregulation of antioxidant nuclear factor erythroid 2-related factor 2 and its dependent genes associated with enhancing renal ischemic preconditioning renoprotection using levosimendan and cilostazol in an ischemia\/reperfusion rat model","volume":"17","author":"Tawfik","year":"2021","journal-title":"Archives of Medical Science"},{"key":"10.7717\/peerj.17885\/ref-28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jphs.2019.02.008","article-title":"Pretreatment with Tilianin improves mitochondrial energy metabolism and oxidative stress in rats with myocardial ischemia\/reperfusion injury via AMPK\/SIRT1\/PGC-1 alpha signaling pathway","volume":"139","author":"Tian","year":"2019","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.7717\/peerj.17885\/ref-29","doi-asserted-by":"publisher","first-page":"113572","DOI":"10.1016\/j.biopha.2022.113572","article-title":"Dexmedetomidine attenuates myocardial ischemia\/reperfusion-induced ferroptosis via AMPK\/GSK-3beta\/Nrf2 axis","volume":"154","author":"Wang","year":"2022","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"10.7717\/peerj.17885\/ref-30","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.atherosclerosis.2014.05.924","article-title":"The cardioprotective effect of sodium tanshinone IIA sulfonate and the optimizing of therapeutic time window in myocardial ischemia\/reperfusion injury in rats","volume":"235","author":"Wei","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.7717\/peerj.17885\/ref-31","article-title":"Study on mechanism and the protective effect of tanshinone II A and prohibitin against myocardial ischemia\/reperfusion injury","author":"Yang","year":"2010","journal-title":"PhD thesis"},{"key":"10.7717\/peerj.17885\/ref-32","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3892\/etm.2014.1820","article-title":"Pharmacological postconditioning with tanshinone IIA attenuates myocardial ischemia-reperfusion injury in rats by activating the phosphatidylinositol 3-kinase pathway","volume":"8","author":"Yuan","year":"2014","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.7717\/peerj.17885\/ref-33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13020-024-00908-y","article-title":"The combination of Tanshinone IIA and Astragaloside IV attenuates myocardial ischemia-reperfusion injury by inhibiting the STING pathway","volume":"19","author":"Zhai","year":"2024","journal-title":"Chinese Medicine"},{"key":"10.7717\/peerj.17885\/ref-34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/fjc.0000000000001206","article-title":"Saikosaponin D alleviates DOX-induced cardiac injury in vivo and in vitro","volume":"79","author":"Zhang","year":"2022","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.7717\/peerj.17885\/ref-35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3969\/j.issn.1007-614x.2010.27.026","article-title":"Effects of tanshinone IIA on myocardial ischemia-reperfusion injury in rats","volume":"12","author":"Zhang","year":"2010","journal-title":"Chinese Community Doctors"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/17885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/17885.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/17885.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/17885.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T11:00:22Z","timestamp":1723806022000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/17885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":35,"alternative-id":["10.7717\/peerj.17885"],"URL":"https:\/\/doi.org\/10.7717\/peerj.17885","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]},"article-number":"e17885"}}